These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38541302)

  • 21. In-hospital case fatality ratio due to COVID-19 in four Brazilian state capitals and its possible temporal relationship with the Gamma variant, 2020-2021.
    Orellana JDY; Marrero L; Horta BL
    Epidemiol Serv Saude; 2021; 30(4):e2021709. PubMed ID: 34852130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convergence in alcohol abuse in Brazilian capitals between genders, 2006 to 2019: what population surveys show.
    Malta DC; Silva AGD; Prates EJS; Alves FTA; Cristo EB; Machado ÍE
    Rev Bras Epidemiol; 2021; 24(suppl 1):e210022. PubMed ID: 33886895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 RNA may rarely be present in a uterine cervix LBC sample at the asymptomatic early stage of COVID 19 disease.
    Ondič O; Černá K; Kinkorová-Luňáčková I; Němcová J; Mejchar B; Chytra J; Bouda J
    Cytopathology; 2021 Nov; 32(6):766-770. PubMed ID: 34033165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors related to inadequate cervical cancer screening in two Brazilian state capitals.
    Martins LF; Valente JG; Thuler LC
    Rev Saude Publica; 2009 Apr; 43(2):318-25. PubMed ID: 19287874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pap smear coverage and factors associated with non-participation in cervical cancer screening: an analysis of the Cervical Cancer Prevention Program in Pernambuco State, Brazil].
    Albuquerque KM; Frias PG; Andrade CL; Aquino EM; Menezes G; Szwarcwald CL
    Cad Saude Publica; 2009; 25 Suppl 2():S301-9. PubMed ID: 19684937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina.
    Arrossi S; Paolino M; Sankaranarayanan R
    Rev Panam Salud Publica; 2010 Oct; 28(4):249-57. PubMed ID: 21152712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer screening: A never-ending developing program.
    Comparetto C; Borruto F
    World J Clin Cases; 2015 Jul; 3(7):614-24. PubMed ID: 26244153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in cervical cancer and its precursor forms to evaluate screening policies in a mid-sized Northeastern Brazilian city.
    Lima MS; Brito ÉAC; Siqueira HFF; Santos MO; da Silva AM; Nunes MAP; Brito HLF; Lima MMM; Cipolotti R; Lima CA
    PLoS One; 2020; 15(5):e0233354. PubMed ID: 32428033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional and social inequalities in the performance of Pap test and screening mammography and their correlation with lifestyle: Brazilian national health survey, 2013.
    Theme Filha MM; Leal MD; Oliveira EF; Esteves-Pereira AP; Gama SG
    Int J Equity Health; 2016 Nov; 15(1):136. PubMed ID: 27852313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors associated with lack of Pap smear screening in a group of postmenopausal Brazilian women].
    Brischiliari SC; Dell'Agnolo CM; Gil LM; Romeiro TC; Gravena AA; Carvalho MD; Pelloso SM
    Cad Saude Publica; 2012 Oct; 28(10):1976-84. PubMed ID: 23090176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Reminder of Skin Cancer During the COVID-19 Pandemic.
    Šitum M; Filipović N; Buljan M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coverage and focus of a cervical cancer prevention program in southern Brazil.
    de Quadros CA; Victora CG; da Costa JS
    Rev Panam Salud Publica; 2004 Oct; 16(4):223-32. PubMed ID: 15615596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case management intervention in cervical cancer prevention: the Boston REACH coalition women's health demonstration project.
    Clark CR; Baril N; Hall A; Kunicki M; Johnson N; Soukup J; Lipsitz S; Bigby J
    Prog Community Health Partnersh; 2011; 5(3):235-47. PubMed ID: 22080772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inequalities in Pap smear screening for cervical cancer in Brazil.
    Martínez-Mesa J; Werutsky G; Campani RB; Wehrmeister FC; Barrios CH
    Prev Med; 2013 Oct; 57(4):366-71. PubMed ID: 23827721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.